318
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The differentiation capability of induced pluripotent stem cells (iPSCs) toward certain cell types for disease modeling and drug screening assays might be influenced by their somatic cell of origin. Here, we have compared the neural induction of human iPSCs generated from fetal neural stem cells (fNSCs), dermal fibroblasts, or cord blood CD34(+) hematopoietic progenitor cells. Neural progenitor cells (NPCs) and neurons could be generated at similar efficiencies from all iPSCs. Transcriptomics analysis of the whole genome and of neural genes revealed a separation of neuroectoderm-derived iPSC-NPCs from mesoderm-derived iPSC-NPCs. Furthermore, we found genes that were similarly expressed in fNSCs and neuroectoderm, but not in mesoderm-derived iPSC-NPCs. Notably, these neural signatures were retained after transplantation into the cortex of mice and paralleled with increased survival of neuroectoderm-derived cells in vivo. These results indicate distinct origin-dependent neural cell identities in differentiated human iPSCs both in vitro and in vivo.

          Related collections

          Author and article information

          Journal
          Cell Rep
          Cell reports
          2211-1247
          Sep 25 2014
          : 8
          : 6
          Affiliations
          [1 ] Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany; Institute of Neuropathology, University Hospital Münster, 48149 Münster, Germany.
          [2 ] Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany; Group of Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute, 20014 San Sebastián, Spain; IKERBASQUE, Basque Foundation for Science, 48011 Bilbao, Spain.
          [3 ] Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4362 Esch-sur-Alzette, Luxembourg; Stem Cell Biology and Regeneration Group, Institute of Cell Biology, ZMBE, Westfälische Wilhelms-University Münster, 48149 Münster, Germany.
          [4 ] Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany.
          [5 ] Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
          [6 ] Division of Neurodegenerative Diseases, Department of Neurology and Center for Regenerative Therapies Dresden (CRTD), University of Technology, 01307 Dresden, Germany.
          [7 ] UNIST, Ulsan National Institute of Science and Technology, Ulsan 689-798, South Korea.
          [8 ] Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany; Faculty of Medicine, University of Münster, 48149 Münster, Germany. Electronic address: office@mpi-muenster.mpg.de.
          [9 ] Institute of Neuropathology, University Hospital Münster, 48149 Münster, Germany.
          Article
          S2211-1247(14)00677-9
          10.1016/j.celrep.2014.08.014
          25220454
          b1118a84-03d2-4433-8ab5-8919f36505e0
          Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article